[1] 李昂,张冰. 685名基层医务人员中药临床用药安全现状调查与思考[J]. 中国药物警戒, 2018, 15(12): 721-727. Li A, Zhang B. Survey and consideration on safety status of traditional Chinese medicine application in 685 primary healthcare workers[J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 721-727. [2] 王辉武. 中医禁忌学[M]. 北京:科学出版社, 2018:15. Wang HW. Contraindication in traditional Chinese medicine[M]. Beijing: Science Press, 2018:15. [3] 沈跃丹. 中医禁忌学说在皮肤病护理中的应用[J]. 现代中西医结合杂志, 1999,8(12): 3-5. Shen YD. Application of contraindication of traditional Chinese medicine in skin disease nursing[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 1999, 8(12): 3-5. [4] 冯爽. 临床化疗药物配伍禁忌分析[J]. 临床医药文献电子杂志, 2018, 5(20): 176-177. Feng S. Analysis of incompatibility of clinical chemotherapeutic drugs[J]. Electronic Journal of Clinical Medical Literature, 2018, 5(20): 176-177. [5] 蔡俊,朱怀军,聂力,等. 基于线性混合模型定量分析帕罗西汀与美托洛尔的药物相互作用[J]. 中国医院药学杂志, 2019, 39(20): 2054-2058. Cai J, Zhu HJ, Nie L, et al. Quantitative analysis of drug interaction between paroxetine and metoprolol based on linear mixed model[J]. Chinese Journal of Hospital Pharmacy, 2019, 39(20): 2054-2058. [6] 刘雅娟,张文锐,宋燕青,等. 407份药品说明书中药物-食物相互作用信息标注情况调查与分析[J]. 中国医院用药评价与分析, 2019, 19(11): 1391-1395. Liu YJ, Zhang WR, Song YQ, et al. Investigation and analysis of labeling of drug-food interaction information in 407 cases of drug directions[J]. Evaluation and Analysis of Drug-Use in Hospitals of China, 2019, 19(11): 1391-1395. [7] 张冰,林志健,张晓朦,等. 国产中成药说明书现状调研与修订完善建议[J]. 药物流行病学杂志, 2017, 26(8): 561-564. Zhang B, Lin ZJ, Zhang XM, et al. Status and improving suggestions of the leaflets of domestic Chinese patent drugs[J]. Chinese Journal of Pharmacoepidemiology, 2017, 26(8): 561-564. [8] 张晓朦,林志健,周伟龙,等. 中成药说明书[禁忌]项的修订完善思考与建议[J]. 药物流行病学杂志, 2017, 26(9): 634-637. Zhang XM, Lin ZJ, Zhou WL, et al. View and suggestions on improving the contraindications of the leaflets of Chinese patent drugs[J]. Chinese Journal of Pharmacoepidemiology, 2017, 26(9): 634-637. [9] 边猛,张冰,王海南,等. 中成药说明书中老年人用药信息修订完善思考[J]. 药物流行病学杂志, 2017, 26(12): 819-823. Bian M, Zhang B, Wang HN, et al. Thought and recommendations on improving the geriatric pharmacy information section of the information leaflets of domestic Chinese patent drugs[J]. Chinese Journal of Pharmacoepidemiology, 2017, 26(12): 819-823. [10] 周伟龙,张冰,王海南,等. 中成药说明书中妇女用药信息的修订完善思考[J]. 药物流行病学杂志, 2017, 26(10): 708-711. Zhou WL, Zhang B, Wang HN, et al. View and recommendations on improving the female pharmacy information of the leaflets of Chinese patent drugs[J]. Chinese Journal of Pharmacoepidemiology, 2017, 26(10): 708-711. [11] 林志健,周伟龙,张冰,等. 中成药说明书中儿童用药信息的修订完善思考[J]. 药物流行病学杂志, 2018, 27(4): 244-248. Lin ZJ, Zhou WL, Zhang B, et al. View and recommendations on improving pediatric pharmacy information of the leaflets of Chinese patent drugs[J]. Chinese Journal of Pharmacoepidemiology, 2018, 27(4): 244-248. [12] 郑蕊,钟长鸣,关曼柯,等. 中药独家品种说明书安全性信息的评价研究[J]. 世界中医药, 2019, 14(10): 2578-2581. Zheng R, Zhong CM, Guan MK, et al. Evaluation study on safety information of instructions for exclusive varieties of Chinese materia medica[J]. World Chinese Medicine, 2019, 14(10): 2578-2581. [13] 张冰,林志健,张晓朦. 基于“识毒-用毒-防毒-解毒”实践的中药药物警戒思想[J]. 中国中药杂志, 2017, 42(10): 2017-2020. Zhang B, Lin ZJ, Zhang XM. Pharmacovigilance of Chinese medicine: practice of cognition,application,prevention and rescue of drug toxicity[J]. China Journal of Chinese Materia Medica, 2017, 42(10): 2017-2020. [14] 李煦照,朱魁元,张帅男. 生物标签的探索:中药药性研究的新模式[J]. 世界科学技术-中医药现代化, 2019, 21(1): 14-18. Li XZ, Zhu KY, Zhang SN. Exploration of bio-label: a new pattern for the study on the nature of Chinese materia medica[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, 2019, 21(1): 14-18. [15] 李加慧. 抗病毒中药的性-效-病关联规则与临床选药思路研究[D]. 南京:南京中医药大学, 2019. Li JH. Research on the association rules of properties, efficacy and viral diseases and clinical drug selection of antiviral traditional Chinese medicine[D]. Nanjing: Nanjing university of Chinese medicine, 2019. [16] 孙玉平,张铁军,曹煌,等. 中药辛味药性表达及在临证配伍中的应用[J]. 中草药, 2015, 46(6): 785-790. Sun YP, Zhang TJ, Cao H, et al. Expression of pungent-taste herbs and their applications in clinical compatibility[J]. Chinese Traditioned and Herbal Drugs, 2015, 46(6): 785-790. [17] 贾嘉明,庄朋伟,张艳军,等. 明清医家对中药“十八反”配伍禁忌的认识[J]. 中医杂志, 2014, 55(9): 809-810. Jia JM, Zhuang PW, Zhang YJ, et al. The doctors’understanding of Ming and Qing Dynasties on the taboos of “eighteen antagonisms” compatibility in traditional Chinese medicine[J]. Journal of Traditional Chinese Medicine, 2014, 55(9): 809-810. [18] 李宁,李玲玲,李春晓,等. 中药十八反和十九畏的历史沿革与临床应用情况探析[J]. 中国药房, 2019, 30(4): 513-517. Li N, Li LL, Li CX, et al. Analysis of the historical evolution of “eighteen incompatible medicaments” and “nineteen medicaments of mutual restraint” of TCM and its clinical application[J]. China Pharmacy, 2019, 30(4): 513-517. [19] 王雨,林志健,董一珠,等. 基于中药用药告知的医疗机构药学服务调研[J]. 中国药师, 2018, 21(12): 2133-2139. Wang Y, Lin ZJ, Dong YZ, et al. Investigation of pharmaceutical services for traditional Chinese medication precautions in medical institutions[J]. China Pharmacist, 2018, 21(12): 2133-2139. [20] 陈玲. 医院门诊药房发药交代的现状与改进措施[J]. 中医药管理杂志, 2018, 26(1): 83-84. Chen L. The current situation and improvement measures of drug delivery account in outpatient pharmacy[J]. Journal of Traditional Chinese Medicine Management, 2018, 26(1): 83-84. [21] 杨冬梅,刘俊,蒋磊. 501种口服药品说明书用药时间和方法的统计分析[J]. 中国医院药学杂志, 2018, 38(17): 1841-1845. Yang DM, Liu J, Jiang L. A statistical analysis of the time and method in package inserts of 501 oral medicines[J]. Chinese Journal of Hospital Pharmacy, 2018, 38(17): 1841-1845. [22] 林志健,张冰,朱熠冰,等. 中药服用后的调护警戒思想探讨[J]. 中国医院用药评价与分析, 2017, 17(12): 1601-1603. Lin ZJ, Zhang B, Zhu YB, et al. Discussion on pharmacovigilance practice of nursing care after taking traditional Chinese medicine[J]. Evaluation and analysis of drug-use in hospitals of China, 2017, 17(12): 1601-1603. [23] 金锐,黄建梅,王宇光,等. 中西药物相互作用研究框架:Ⅰ/Ⅱ/Ⅲ类途径的构建[J]. 中国中药杂志, 2016, 41(3): 545-549. Jin R, Huang JM, Wang YG, et al. Framework on drug interactions between herbal medicine and western medicine: building Ⅰ/Ⅱ/Ⅲ class pathways of interactions[J]. China Journal of Chinese Materia Medica, 2016, 41(3): 545-549. [24] 金锐,王宇光,薛春苗,等. 中成药处方点评的标准与尺度探索(七):中西药相互作用[J]. 中国医院药学杂志, 2015, 35(19): 1713-1718. Jin R, Wang YG, Xue CM, et al. Exploration on criteria and compromise in prescription review of Chinese patent medicines VII: interaction with Western medicine [J]. Chinese Journal of Hospital Pharmacy, 2015, 35(19): 1713-1718. [25] 缪睿,邬海萍,王虹,等. 中国药典2015年版妊娠哺乳期禁忌相关中成药整理及思考[J]. 中国现代应用药学, 2016, 33(5): 618-623. Miu R, Wu HP, Wang H, et al. Thoughts upon recording and sorting-out the Chinese patent medicine contraindications (gestation & lactation) in Chinese Pharmacopoeia (2015 Edition) [J]. Chinese Journal of Modern Applied Pharmacy, 2016, 33(5): 618-623. [26] 金锐,王宇光,薛春苗,等. 中成药处方点评的标准与尺度探索(十) :儿童用药[J]. 中国医院药学杂志, 2017, 37(11): 1003-1008. Jin R, Wang YG, Xue CM, et al. The exploration on criteria and compromise in the prescription review of Chinese patent medicines (X): medication for children[J]. Chinese Journal of Hospital Pharmacy, 2017, 37(11): 1003-1008. [27] 林梅青,郭进建. 中药毒性再思考[J]. 医学与哲学, 2019, 40(15): 71-74. Lin MQ, Guo JJ. Reflection on the toxicity of traditional Chinese medicine[J]. Medicine and Philosophy, 2019, 40(15): 71-74. [28] Gao Y, Liang A, Fan X, et al. Safety research in traditional Chinese medicine: methods, applications, and outlook[J]. Engineering, 2019, 5(1): 76-82. [29] 杨世磊,刘克辛. 药物转运体介导的中药及单体药物相互作用的研究进展[J]. 药物评价研究, 2019, 42(1): 194-203. Yang SL, Liu KX. Development of research on drug transporters mediated interaction between Chinese medicine and monomers[J]. Drug Evaluation Research, 2019, 42(1): 194-203. [30] 王新芳,魏琴,罗永皎,等. 中成药处方药、非处方药说明书规范性分析[J]. 中成药, 2019, 41(8): 2022-2024. Wang XF, Wei Q, Luo YJ, et al. Normative analysis of instructions for prescription and over-the-counter drugs of proprietary Chinese Medicine[J]. Traditional Chinese Patent Medicine, 2019, 41(8): 2022-2024. [31] 王文青,韩仙鸽,刘津,等. 我院门诊435种中成药说明书信息调查与分析[J]. 中国药房, 2019, 30(9): 1288-1292. Wang WQ, Han XG, Liu J, et al. Investigation and analysis of 435 kinds of Chinese patent medicine instructions in outpatient department of our hospital[J]. China Pharmacy, 2019, 30(9): 1288-1292. [32] 刘欣,张冰,王海南,等. 中成药说明书[注意事项]的修订完善思考与建议[J]. 药物流行病学杂志, 2018, 27(1): 45-49. Liu X, Zhang B, Wang HN, et al. View and suggestions on improving the ‘Precaution’ section of the leaflets of Chinese patent drugs[J]. Chinese Journal of Pharmacoepidemiology, 2018, 27(1): 45-49. |